Literature DB >> 16912153

Influence of the microenvironment on melanoma cell fate determination and phenotype.

Lynne-Marie Postovit1, Elisabeth A Seftor, Richard E B Seftor, Mary J C Hendrix.   

Abstract

Tumor cells communicate bidirectionally with the surrounding microenvironment, sending and receiving topographical and molecular cues that direct diverse cellular phenomena, including differentiation, growth, and invasion. The microenvironment has long been acknowledged as a facilitator of melanoma progression, and recent studies have illuminated tumor-associated factors, including hypoxia and the extracellular matrix, as important mediators of melanocyte transformation and transdifferentiation. Although these findings portray the microenvironment as a perilous obstacle to the successful treatment of advanced melanomas, it is important to note that certain molecular milieus may be capitalized on as potential treatment modalities. Indeed, our group and others have elucidated the unique ability of embryonic microenvironments to normalize aggressive melanoma cells toward a more benign melanocytic phenotype. The microenvironment therefore presents a novel target for the treatment and ultimately the prevention of melanoma progression and metastasis.

Entities:  

Mesh:

Year:  2006        PMID: 16912153     DOI: 10.1158/0008-5472.CAN-06-0731

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Nodal signaling activates the Smad2/3 pathway to regulate stem cell-like properties in breast cancer cells.

Authors:  Wenchen Gong; Baocun Sun; Huizhi Sun; Xiulan Zhao; Danfang Zhang; Tieju Liu; Nan Zhao; Qiang Gu; Xueyi Dong; Fang Liu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers.

Authors:  Kriti Mittal; Henry Koon; Paul Elson; Pierre Triozzi; Afshin Dowlati; Helen Chen; Ernest C Borden; Brian I Rini
Journal:  Cancer Biol Ther       Date:  2014-05-19       Impact factor: 4.742

3.  Discovering Molecular Targets in Cancer with Multiscale Modeling.

Authors:  Zhihui Wang; Veronika Bordas; Thomas S Deisboeck
Journal:  Drug Dev Res       Date:  2011-02-01       Impact factor: 4.360

Review 4.  CD133-targeted niche-dependent therapy in cancer: a multipronged approach.

Authors:  Anthony B Mak; Caroline Schnegg; Chiou-Yan Lai; Subrata Ghosh; Moon Hee Yang; Jason Moffat; Mei-Yu Hsu
Journal:  Am J Pathol       Date:  2014-02-28       Impact factor: 4.307

5.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

6.  Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.

Authors:  Andy J Chien; Erin C Moore; Anke S Lonsdorf; Rima M Kulikauskas; Bonnie Gould Rothberg; Aaron J Berger; Michael B Major; Sam T Hwang; David L Rimm; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

Review 7.  Building a framework for embryonic microenvironments and cancer stem cells.

Authors:  Antonio Ruiz-Vela; Cristóbal Aguilar-Gallardo; Carlos Simón
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

8.  Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.

Authors:  Francesca Spinella; Laura Rosanò; Martina Del Duca; Valeriana Di Castro; Maria Rita Nicotra; Pier Giorgio Natali; Anna Bagnato
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

9.  Human Embryonic-like ECM (hECM) Stimulates Proliferation and Differentiation in Stem Cells While Killing Cancer Cells.

Authors:  Emmett Pinney; Michael Zimber; Aaron Schenone; Mayra Montes-Camacho; Frank Ziegler; Gail K Naughton
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.